TrialAesthetic surgery journal2024

Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar Lines.

Sachin M Shridharani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.